about
Trial of a 5-day dosing regimen of temozolomide in patients with relapsed small cell lung cancers with assessment of methylguanine-DNA methyltransferase.Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I diseaseThe new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should knowThe tumoral and stromal immune microenvironment in malignant pleural mesothelioma: A comprehensive analysis reveals prognostic immune markersTumoral CD10 expression correlates with aggressive histology and prognosis in patients with malignant pleural mesothelioma.Tumor Budding Correlates With the Protumor Immune Microenvironment and Is an Independent Prognostic Factor for Recurrence of Stage I Lung Adenocarcinoma.Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutationInternational Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification predicts occult lymph node metastasis in clinically mediastinal node-negative lung adenocarcinoma.Nuclear estrogen receptor-α expression is an independent predictor of recurrence in male patients with pT1aN0 lung adenocarcinomas, and correlates with regulatory T-cell infiltrationPathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint.Comprehensive pathological analyses in lung squamous cell carcinoma: single cell invasion, nuclear diameter, and tumor budding are independent prognostic factors for worse outcomes.Mesothelin overexpression is a marker of tumor aggressiveness and is associated with reduced recurrence-free and overall survival in early-stage lung adenocarcinoma.Ki-67 antigen in lung neuroendocrine tumors: unraveling a role in clinical practice.ITMIG consensus statement on the use of the WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting.Standardized terminology and nomenclature for respiratory cytology: The Papanicolaou Society of Cytopathology guidelines.The International Association Study Lung Cancer (IASLC) Strategic Screening Advisory Committee (SSAC) response to the USPSTF recommendations.The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer.The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung CancerTumor genetics and survival of thymic neuroendocrine neoplasms: A multi-institutional clinicopathologic study[New WHO classification of lung adenocarcinoma and preneoplasia]Can IASLC/ATS/ERS subtype help predict response to chemotherapy in small biopsies of advanced lung adenocarcinoma?Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
P50
Q33417537-9FA4AF28-91A2-46CF-8CC7-E1CEF72FE1A0Q34181641-77C7897A-65F0-4876-8B8D-9F770F0CE141Q34748124-58D26B79-3432-478E-A4E6-6779EE3E6F50Q35799028-C1907A8B-6A99-4508-8FC9-CFFF8105F70FQ35880415-6EF72528-038C-4A45-8BDA-B521E0C53A7BQ36015463-B816366C-B3D4-4C26-9643-403D7925A15FQ36337437-510865F2-4605-46E0-B24D-6B8F4F55B735Q36371292-33D72DF2-C2B8-4383-86AE-732E790D68C2Q36413817-A32B2597-BE7E-4063-992A-1D3CA47A7516Q36525431-C5768E02-A4BB-422B-B46D-791D9A63044AQ36726239-437073CE-2E88-4E4E-B959-ACE1561840B4Q37621377-97F7D41B-1ABF-4829-9CED-DD12FCCB1B02Q38187221-7F1B1B1A-2153-4C70-B11C-EC64BAD7FA9DQ38203759-7BE7D990-863C-4476-BFB8-45AA302E2276Q38779899-FBB0C1C7-7DA2-40F1-B1C4-A8FADFBF9B3EQ46618410-23CE5A87-73F6-4648-90CE-ACD61DEE2294Q49014865-D087054E-3972-4E90-9EAF-10A26F31906BQ57272532-D4FB0008-2F21-4810-9CBA-A60805C89F83Q57700198-B6D825D5-8B77-4494-A514-05B5EDAFF10AQ87123278-60180578-5875-4EF0-B2EA-015B9A0A00ECQ87798111-E7E1BA1A-58E9-4E20-918C-9DFF4A1DDE7CQ91247291-124C8942-A452-475D-8E97-B78185B57647
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
William D. Travis
@ast
William D. Travis
@en
William D. Travis
@es
William D. Travis
@nl
William D. Travis
@sl
type
label
William D. Travis
@ast
William D. Travis
@en
William D. Travis
@es
William D. Travis
@nl
William D. Travis
@sl
prefLabel
William D. Travis
@ast
William D. Travis
@en
William D. Travis
@es
William D. Travis
@nl
William D. Travis
@sl
P1053
E-9335-2015
P106
P1153
55979011700
P21
P31
P3829
P496
0000-0003-3160-6729